Simplifying molecular subtypes of metastatic gastric cancer
Dr Maria Alsina - Vall d'Hebron Instituto de Oncología (VHIO), Barcelona, Spain
8 Oct 2019
Quality of life results from pembrolizumab vs chemotherapy in gastric or gastroe...
Dr Maria Alsina - Vall d'Hebron Instituto de Oncología (VHIO), Barcelona, Spain
8 Oct 2019
VOLFI: FOLFOXIRI and panitumumab in RAS wild-type metastatic colorectal cancer
Dr Dominik Modest - Charité Universitätsmedizin Berlin, Berlin, Germany
7 Oct 2019
SPICE: Analysis of enadenotucirev plus nivolumab in metastatic colorectal cancer...
Prof Marwan Fakih - City of Hope National Medical Center, Duarte, USA
4 Oct 2019
IMPALA results: Lefitolimod vs standard of care in metastatic colorectal cancer
Dr Ramon Salazar - Catalan Institute of Oncology, Barcelona, Spain
4 Oct 2019
AMG 510: A novel molecule targeting KRAS G12C mutant solid tumours
Prof Marwan Fakih - City of Hope National Medical Center, Duarte, USA
4 Oct 2019
INVICTUS: Assessing the safety and efficacy of ripretinib in patients with advan...
Prof Margaret von Mehren - Fox Chase Cancer Center, Philadelphia, USA
3 Oct 2019
BEACON: Encorafenib plus cetuximab with or without binimetinib for BRAF V600E–mu...
Prof Josep Tabernero - Vall d´Hebron Institute of Oncology (VHIO), Barcelona, Sp...
30 Sep 2019
ATTRACTION-3: Nivolumab versus chemotherapy in advanced oesophageal squamous cel...
Prof Byoung Chul Cho - Yonsei University, Seoul, South Korea
29 Sep 2019
Advances in the treatment of peritoneal metastases in gastric cancer
Dr Geraldo Alves - Hospital Santa Rosa, Brasil
7 Aug 2019
Optimising regorafenib dosing in mCRC
Dr Axel Grothey and Dr Tanios Bekaii-Saab
2 Aug 2019
Radiotherapy for liver cancer, and neoadjuvant therapy for rectal cancer
Dr Parag Parikh - Mayo Clinic, Rochester, USA
17 Jul 2019
